✦ LIBER ✦

Diferences in virological and biochemical breakthroughs in patients with precore mutant HBV related liver diseases treated with lamivudine

✍ Scribed by Themistoklis Vasiliadis; Kaliopi Patsiaoura; Adamos Saveriadis; Despina Kolokotroni; Anastasios Voutsas; Olga Giouleme; Nikolaos Nikolaidis; Eleni Orphanou; Nikolaos Evgenidis

Book ID: 118565398
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 223 KB
Volume: 36
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(02)80482-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Course of virologic breakthroughs under

Course of virologic breakthroughs under lamivudine therapy in patients with precore mutant HBV related liver disease

✍ Papatheodoridis, George V.; Dimou, Evangelini; Papadimitropoulos, Vassilios; Had 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 175 KB

Course of virologic breakthroughs (VBTs)

Course of virologic breakthroughs (VBTs) under lamivudine (LAM) therapy in patients (PTS) with precore mutant HBV related chronic liver disease (CLD)

✍ G.V. Papatheodoridis; E. Dimou; V. Papadimitropoulos; A. Laras; S. Hadziyannis 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 131 KB

Long term lamivudine therapy in patients

Long term lamivudine therapy in patients with precore mutant HBV related liver disease

✍ Themistoklis Vasiliadis; Kalliopi Patsiaoura; Adamos Saveriadis; Despina Kolokot 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 115 KB

Course of virologic breakthroughs under

Course of virologic breakthroughs under long-term lamivudine in HBeAg-negative precore mutant HBV liver disease

✍ George V. Papatheodoridis; Evangelini Dimou; Andreas Laras; Vassilios Papadimitr 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 138 KB

Long-term lamivudine monotherapy (LAM) i

Long-term lamivudine monotherapy (LAM) in patients with HBeAg-negative HBV related chronic liver disease [HBeAg(−)CLD]: predictors of virological (VBTs) and biochemical (BBTs) breakthroughs

✍ George Papatheodoridis; Evangelini Dimou; Andreas Laras; Vasilios Papadimitropou 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 222 KB

Efficacy of lamivudine therapy in patien

Efficacy of lamivudine therapy in patients with HBV related liver disease

✍ N. Campo; G. Dardano; S. Caglieris; L. Mondello; R. Testa; U. Valente; G. Celle; 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 176 KB